Saxenda for weight loss: separating real results from TikTok hype

What did @shanna_beth actually say?

Shanna shared a six-week Saxenda update, claiming she lost 31 pounds since starting the medication. She got her prescription through her primary care doctor, pays roughly four dollars a month out of pocket because her insurance covers it, and described manageable nausea that varies day to day. She also mentioned eating smaller portions and making herself sick when she tried to eat too much.

To her credit, she gave real context: she tried phentermine, tried working with a personal trainer until she got injured, and was approved for bariatric surgery before deciding to try GLP-1 injections first. That's not a casual dieter reaching for a quick fix. That's someone with a documented weight history working through legitimate options in a reasonable order.

She also apologized to viewers who can't afford Saxenda without coverage, which is a more self-aware disclosure than most influencers bother to make.

Does the science back this up?

The 31-pound figure is the one that deserves scrutiny. It is on the high end of what clinical data would predict, but not impossible given starting weight, water loss, and individual variation.

In the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine), participants on liraglutide 3.0 mg lost an average of 8.4 kg (about 18.5 lbs) over 56 weeks, compared to 2.8 kg on placebo. That's a full year, not six weeks. However, early weight loss tends to be faster, and a large portion of initial loss is water weight tied to glycogen depletion and reduced sodium retention from eating less. Someone with a higher starting body weight can lose more in absolute pounds early on.

Thirty-one pounds in six weeks is roughly 5 pounds per week on average. That exceeds what most clinical trials document as average, but averages obscure individual outliers. It is not biologically impossible, especially if she started at a significantly higher weight. What it is, is not typical, and viewers should not use her number as a benchmark for their own expectations.

Her description of nausea as inconsistent and manageable tracks well with the literature. Nausea is the most common side effect of liraglutide, reported in up to 39.3% of participants in SCALE trials, and it tends to peak early and diminish over time as the body adjusts.

What did they get wrong (or right)?

She got the side effect picture mostly right. Nausea that comes and goes, eating smaller portions involuntarily, and feeling sick when overeating are all consistent with how liraglutide works: it slows gastric emptying and acts on appetite-regulating receptors in the brain. She is not fabricating symptoms for content.

What she did not address, and what is worth flagging, is that a 31-pound loss in six weeks should involve a conversation with her doctor about whether that rate is sustainable or whether it signals something worth monitoring. Rapid weight loss can accelerate gallstone formation. The SCALE trials noted cholelithiasis occurred in 2.5% of liraglutide users versus 1.0% on placebo. That is not a reason to stop the medication, but it is a reason to stay in contact with your prescriber, not just TikTok.

She also casually mentioned being prescribed Saxenda by her primary doctor, which is completely legitimate and increasingly common. Primary care physicians can and do prescribe GLP-1 medications for obesity. Nothing problematic there.

What should you actually know?

If you are watching this video and thinking about Saxenda, here is what the data actually says. Average weight loss on liraglutide 3.0 mg at one year is roughly 5 to 8 percent of body weight in most trials, though some individuals lose significantly more. The drug is FDA-approved for chronic weight management in adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition.

Insurance coverage for Saxenda varies dramatically. Many commercial plans cover it; Medicare Part D historically has not, though this is shifting. The list price without insurance runs over 1,300 dollars per month. Shanna's four-dollar copay is genuinely unusual and reflects strong employer-sponsored coverage, not the norm.

A few things to watch for if you are on liraglutide:

• Nausea and vomiting are common early on and usually improve after the first few weeks.
• Gallbladder issues are a documented risk with rapid weight loss on GLP-1 drugs. Report right upper abdominal pain to your doctor.
• Liraglutide carries a boxed warning for thyroid C-cell tumors observed in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma.
• Weight loss results vary significantly. Do not calibrate your expectations to an influencer's six-week highlight reel.

Shanna's experience is real, but it is one data point from one person. Your weight, your starting dose, your diet, your hormones, and your medical history all shape your outcome differently.